Latest Anxiolytics Stories

BOCA RATON, Fla., March 26, 2013 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Aptalis Pharmatech, Inc. to market Propranolol Hydrochloride Extended-Release Capsules, USP the generic version of Inderal® LA by Akrimax Pharmaceuticals, LLC, under Aptalis Pharmatech, Inc.'s Abbreviated New Drug Application (ANDA). The product was approved by the U.S. Food and Drug Administration (FDA) on July 15, 2011. Under the terms of...

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) is requiring pharmaceutical companies to lower the recommended doses of popular sleeping pills, due to the potential risk of injury resulting from morning drowsiness associated with the medications in recent studies. According to Reuters, studies have demonstrated that pills containing the prescription drug zolpidem (which include products sold under the brand names Ambien, Edluar,...

Cell Press Fly larvae fed on alcohol-spiked food for a period of days grow dependent on those spirits for learning. The findings, reported in Current Biology, a Cell Press publication, on November 29th, show how overuse of alcohol can produce lasting changes in the brain, even after alcohol abuse stops. The report also provides evidence that the very human experience of alcoholism can be explored in part with studies conducted in fruit flies and other animals, the researchers say....

MORRISTOWN, N.J., Oct. 22, 2012 /PRNewswire/ -- P.L. Thomas & Co. Inc. (Morristown, NJ) and HG&H Pharmaceuticals (Pty) Ltd. (Bryanston, South Africa) announced today that they will conduct a full-scale launch of Zembrin® Sceletium tortuosum extract at Supply Side West, 3-5 November in Las Vegas. Over the last two years, the companies have been engaged in a series of successful clinical and safety studies, have completed the NDI notification process, and will now make the...

DENVER, July 25, 2012 /PRNewswire/ -- BIOFUEL ENERGY CORP. (NASDAQ:BIOF) announced today that it will be releasing its second quarter 2012 earnings on Thursday, August 9, 2012, after the market closes. The Company plans to host a conference call on Friday, August 10, 2012, beginning at 11:00 a.m. (EDT) to discuss the results. To participate, please dial (800) 944-8766. The participant code for the call is 29611. This call will be available for phone playback for 30 days by dialing...

Even moderate use of sleeping pills carries potential long-term risks. Dr. Dan Naim, a sleep specialist, recommends a non-drug route for treating insomnia. Los Angeles, CA (PRWEB) July 12, 2012 Early death is one of the risks associated with sleeping pills, according to a new study. While up to 10 percent of adults in the U.S. take some form of sleep aid medication, Dr. Dan Naim of Los Angeles Sleep Study Institute recommends sleeping pills only after non-drug routes are exhausted and for...

LONDON, June 11, 2012 /PRNewswire/ -- Alex Herriot, 19, collapsed in the main area at the festival on Saturday 9th June. The teenager was stabilised in the hospital tent before being transferred to Raigmore Hospital in Inverness. Two members of his party were also hospitalised after consuming the drug and police are currently investigating whether Benzo Fury was the cause of his death. Sadly, Alex failed to respond to treatment and died in the early hours of Sunday morning....

A novel mechanism for anxiety behaviors, including a previously unrecognized inhibitory brain signal, may inspire new strategies for treating psychiatric disorders, University of Chicago researchers report. By testing the controversial role of a gene called Glo1 in anxiety, scientists uncovered a new inhibitory factor in the brain: the metabolic by-product methylglyoxal. The system offers a tantalizing new target for drugs designed to treat conditions such as anxiety disorder, epilepsy,...

Antidepressive drugs reduce the mortality rate of schizophrenic patients, while treatment with bensodiazepines greatly increases it, especially as regards suicide. Giving several antipsychotics simultaneously, however, seems to have no effect at all. This according to a new study examining different drug combinations administered to patients with schizophrenia. "We weren't aware that the beneficial effects of antidepressives were so powerful," says Jari Tiihonen, professor of clinical...

PHILADELPHIA, May 8, 2012 /PRNewswire/ -- The new prescription sleep aid Intermezzo (zolpidem tartrate) sublingual tablet CIV is the first and only prescription sleep aid approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep, and the patient has at least four hours of bedtime remaining before the planned time of waking. Intermezzo has gender-specific dosing (1.75 mg for...